News

A reliable blood test for Alzheimer’s disease – is it becoming a reality?

1024 683 Anna Stelling, PhD

The increasing number of patients suffering from dementia caused by Alzheimer’s disease (AD) is a significant challenge for society and requires action by healthcare professionals and researchers worldwide. One important…

read more

Speaking to Prof. Günther Deuschl – “The world is not a world of competitors, it is a world of collaborators.“

1041 1092 Anna Stelling, PhD

Even now, after having retired, Prof. Günther Deuschl’s ultimate goal is to cure patients. As an expert in movement disorders, he has contributed to this field substantially during his career.…

read more

New evidence against fluoxetine in stroke recovery

5805 3875 Anna Stelling, PhD

Stroke is a very common disease that leads to disability in around half of its survivors.1 It has been believed that fluoxetine, a selective serotonin-reuptake inhibitor (SSRI), could improve neurological…

read more

Across specialties – a study on brain complications in COVID-19 patients

5508 3672 Anna Stelling, PhD

Since December 2019, when clinicians first reported infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19), researchers have been trying to decipher the effects of the virus on…

read more

Journal watch: Trial sheds light on optimal management of brain arteriovenous malformation

6036 4024 Anna Stelling, PhD

The Background There has been longstanding uncertainty of whether medical management alone or additional interventional therapy is better for patients with a brain arteriovenous malformation that has never bled. Reports…

read more

Head impacts associated with depression and decreased cognitive function

6000 4000 Anna Stelling, PhD

Current research suggests that repetitive head impacts (RHI) resulting from contact sports, military service, domestic violence, or other sources are associated with cognitive and neuropsychiatric disorders.1 It has been proposed…

read more

CONy 2020

4896 3264 Anna Stelling, PhD

The world Congress on Controversies in Neurology (CONy) this year will take place from the 2nd until the 5th of October 2020 on a virtual platform. The congress will cover…

read more

Researchers found how ketamine works in depression – but that’s not all

6016 4016 Anna Stelling, PhD

Depression is a widely-spread disease, with over 264 million people being affected worldwide.1 For a subset of patients suffering from major depressive disorder (MDD), administering low doses of the anaesthetic…

read more

Malaria drug brings new hope for glioblastoma patients

4794 3196 Anna Stelling, PhD

Glioblastoma is a very aggressive form of cancer. Even though there is a low number of patients who live longer than 5 years after diagnosis – a statistic that researchers…

read more

Does COVID-19 affect the brain?

1920 1080 Anne Carter, MA (Cantab)

With EAN going virtual this year, the global SARS-CoV2 pandemic was never far from the attendees’ minds. After a brief overview of the putative mechanisms for SARS-CoV2 accessing the brain,…

read more
Brainwork is supported by unrestricted grants from: